The Aperio Blog
Aperio’s Stacey King and Mike Ferree Talk Risk Based Quality Management at SCDM 2021
September 15, 2021
Aperio’s Stacey King will facilitate an On Demand session for Society for Clinical Data Management 2021 titled “Risk Based Quality Management – Every Piece of the Puzzle Matters.”
During the session, Stacey and her esteemed panelists will discuss the different components of RBQM; the roles and responsibilities of RBQM and Centralized Monitoring Analytics; why it’s critical to implement a QbD approach to study design; and how the field of Clinical Data Management is evolving.
Stacey will be joined by a panel of industry experts, including Aperio’s Micheal Ferree, Medidata’s Brian Barnes, Pfizer’s Crupa K., and CMED’s Rachel Oakley.
The On Demand session is available on the Society for Clinical Data Management (SCDM) 2021 website Sept. 19th -29th. You can access the session here.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes offers essential services for today’s complex, data-intensive oncology and rare disease clinical trials: rock-solid fit-for-purpose database development and management, unmatched analytics expertise, and powerful holistic tools that deliver the most coherent and actionable views of essential data. Just as important, in an industry flooded with promises, we make only one: We tell the truth, no matter what.
